Gadopiclenol: A q = 2 Gadolinium-Based MRI Contrast Agent Combining High Stability and Efficacy.

Objectives: Gadopiclenol is a q = 2 pyclen gadolinium-based contrast agent (GBCA) recently approved by the Food and Drug Administration, European Medicines Agency, and other European countries. The aim of this report is to demonstrate its stability in multiple stressed in vitro conditions and in vivo, in rat kidney, while maintaining its higher relaxivity compared with conventional GBCAs on the market.

Materials And Methods: Both gadopiclenol and its chemical precursor Pi828-Gd were characterized and compared with q = 1 gadolinium (Gd) complexes.

Reduced nontarget embolization and increased targeted delivery with a reflux-control microcatheter in a swine model.

Purpose: To evaluate the potential differences in non-target embolization and vessel microsphere filling of a reflux-control microcatheter (RCM) compared to a standard end-hole microcatheter (SEHM) in a swine model.

Materials And Methods: Radiopaque microspheres were injected with both RCM and SEHM (2.4-Fr and 2.

Lubrication with Soft and Hard Two-Dimensional Colloidal Arrays.

Normal and friction forces between immobilized two-dimensional (2D) homogeneous non-close-packed colloidal arrays made of different particles are compared in aqueous media. Soft pH-responsive (microgels) and nonresponsive hard (silica) particles of different sizes were used to create the 2D arrays. The results show that the friction of soft responsive structured layers can be successfully modulated by varying the pH, with a friction coefficient varying by nearly 3 orders of magnitude (10 to 1).